A61K 38/13
Cyclosporins
A61K38/13 (Cyclosporins) appears on 1,103 US grants and 2,011 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,103
- Published applications
- 2,011
- Assignees
- 820
- Inventors
- 2,868
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 12 | 0 |
| 1997 | 32 | 0 |
| 1998 | 33 | 0 |
| 1999 | 36 | 0 |
| 2000 | 26 | 0 |
| 2001 | 36 | 16 |
| 2002 | 25 | 46 |
| 2003 | 27 | 65 |
| 2004 | 22 | 70 |
| 2005 | 19 | 60 |
| 2006 | 25 | 74 |
| 2007 | 18 | 72 |
| 2008 | 18 | 66 |
| 2009 | 13 | 62 |
| 2010 | 33 | 79 |
| 2011 | 22 | 61 |
| 2012 | 23 | 78 |
| 2013 | 41 | 77 |
| 2014 | 50 | 107 |
| 2015 | 52 | 101 |
| 2016 | 46 | 106 |
| 2017 | 53 | 89 |
| 2018 | 51 | 82 |
| 2019 | 57 | 94 |
| 2020 | 60 | 93 |
| 2021 | 44 | 118 |
| 2022 | 45 | 105 |
| 2023 | 42 | 104 |
| 2024 | 43 | 69 |
| 2025 | 34 | 73 |
| 2026 | 25 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of high molecular weight hyaluronic acid as ocular transporting vehicle22 Sep 2026US 12,741,027 B2I. Com Medical GmbH
- Calixarene compounds and uses thereof25 Aug 2026US 12,714,682 B2Universität Wien
- Methods and compositions for the treatment of hair loss4 Aug 2026US 12,697,334 B2Aneira Pharma, Inc.
- Medicament for improving or preventing symptoms relating to retina and/or light reception and method for screening for substance capable of improving or preventing symptoms relating to retina and/or light reception4 Aug 2026US 12,697,367 B2Osaka University
- TSG6 polypeptide fragment for dry eye disease4 Aug 2026US 12,697,368 B2The University of Manchester
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Anti-cd40 antibodies and uses thereof10 Sep 2026US 2026/0263595 A1Beth Israel Deaconess Medical Center, Inc.
- Novel drug delivery systems and methods of making and using same20 Aug 2026US 2026/0240789 A1The Texas A&M University System
- Treatment and prevention of agent-induced liver conditions or diseases20 Aug 2026US 2026/0240941 A1Farsight Medical Technology (Shanghai) Co., Ltd.
- Cell therapy for diabetes in transplant recipients13 Aug 2026US 2026/0232736 A1Vertex Pharmaceuticals Incorporated
Most cited
By later US patents
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014
- Methods for enhancing vascularization of implant devices356US 5,569,462 ABaxter International Inc. · 1996
- Compositions and methods for improved delivery of hydrophobic agents332US 6,451,339 B2Lipocine Inc. · 2002
- Pharmaceutical compositions containing an omega-3 fatty acid oil306US 6,284,268 B1Cyclosporine Therapeutics Limited · 2001